Haleon plc: Director Declaration
21 January 2026: Haleon plc (LSE/NYSE: HLN) announces that Dawn Allen, Chief Financial Officer, has been appointed Chair of the Audit & Risk Committee of ITV plc with effect from 5 March 2026.
Dawn has served as a Non‑Executive Director of ITV plc and a member of its Audit & Risk Committee since 2 October 2023.
This notification is made in accordance with the requirements of Listing Rule 6.4.9R(2).
Amanda Mellor
Company Secretary
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
For more information, please visit www.haleon.com.